Putnam Investments’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $30.5M | Buy |
365,335
+147,486
| +68% | +$12.3M | 0.04% | 175 |
|
|
2023
Q3 | $6.42M | Buy |
217,849
+7,519
| +4% | +$222K | 0.01% | 393 |
|
|
2023
Q2 | $6.86M | Buy |
210,330
+10,662
| +5% | +$348K | 0.01% | 390 |
|
|
2023
Q1 | $7.03M | Sell |
199,668
-129
| -0.1% | -$4.54K | 0.01% | 383 |
|
|
2022
Q4 | $9.15M | Buy |
199,797
+694
| +0.3% | +$31.8K | 0.02% | 304 |
|
|
2022
Q3 | $9.65M | Sell |
199,103
-991
| -0.5% | -$48K | 0.02% | 296 |
|
|
2022
Q2 | $7.86M | Buy |
200,094
+1,014
| +0.5% | +$39.8K | 0.01% | 341 |
|
|
2022
Q1 | $7.33M | Buy |
199,080
+4,069
| +2% | +$150K | 0.01% | 413 |
|
|
2021
Q4 | $8.89M | Buy |
195,011
+63,357
| +48% | +$2.89M | 0.01% | 398 |
|
|
2021
Q3 | $4.71M | Buy |
+131,654
| New | +$4.71M | 0.01% | 538 |
|